Cullinan Mica

PharmaceuticalsSeries AUS

Latest round

Series A

Last raised

Jun 2020

Total raised

$26M

Investors

4

About Cullinan Mica

Founded in 2016 and based in California, US, Cullinan Mica Corp. operates as a clinical testing company for the collaboration of CLN-619 monoclonal antibody novel therapy for cancer and other diseases into human testing.

Who invested in Cullinan Mica

4 investors across 1 round

See all investors in Cullinan Mica

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jun 11, 2020

    Amount

    $26M

    Investors

    Locked

Questions about Cullinan Mica

Who invested in Cullinan Mica?

Cullinan Mica has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Cullinan Mica raised?

Cullinan Mica has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Cullinan Mica last raise money?

Cullinan Mica's most recent round on record is a Series A, in Jun 2020.

What does Cullinan Mica do?

Founded in 2016 and based in California, US, Cullinan Mica Corp.

Where is Cullinan Mica headquartered?

Cullinan Mica is headquartered in US.

Which VCs invest in companies like Cullinan Mica?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Cullinan Mica's stage. Their profiles are linked below.

Raising like Cullinan Mica? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.